- Global Obesity Drug Market Valued at $95 Billion Faces Challenges from Gastrointestinal Side Effects geneonline.com
- Obesity: Why New Medications Are Not Miracle Cures NDTV
- Opinion: The GLP-1 Paradox—Why Is a $95B Obesity Market Ignoring Its Biggest Problem? BioSpace
- Obesity and diabetes CALOR study AstraZeneca
- Global obesity epidemic: New drugs offer hope, but prevention remains the key, say experts Daijiworld